SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS*

Authors


  • *

    Aided by grants AMO2375, AI04444, AM7513, AMO6283, AMO6344, HEO7735, AMO7772, AIO4152, FR00051, FR00069, and FR3 from the United States Public Health Service, a grant from the California Cancer Research Coordinating Committee and a grant from the Medical Research Council of Great Britain. Computational assistance was obtained from U.C.L.A. Health Sciences Computer Facility.

Ancillary